SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001072613-15-000441
Filing Date
2015-11-03
Accepted
2015-11-03 16:29:55
Documents
1
Group Members
ANTHONY A. FLORENCE JR.DAVID M. MOTTFOREST BASKETTHARRY R. WELLERJON M. SAKODAJOSHUA MAKOWERKRISHNA S. KOLLURINEA 15 GP LLCNEA PARTNERS 15 L.P.NEW ENTERPRISE ASSOCIATES 15 L.P.PETER J. BARRISPETER W. SONSINIRAVI VISWANATHANSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 STRONGBRIDGE BIOPHARMA, INC. strongbridge-sch13d_17866.htm SC 13D 536255
  Complete submission text file 0001072613-15-000441.txt   538306
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Subject) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: SC 13D | Act: 34 | File No.: 005-89153 | Film No.: 151194081
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000
Growth Equity Opportunities IV, LLC (Filed by) CIK: 0001644965 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D